Condition
Exudative Macular Degeneration clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Exudative Macular Degeneration clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Austria (1)). By phase: Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using artificial intelligence to treat neovascular age-related macular degeneration
This study is testing if using artificial intelligence can help doctors find better ways to treat people with neovascular age-related macular degeneration while making the treatment process easier for patients.
-
Low-dose oral doxycycline targeting MMP-9 for persistent wet AMD
This trial tests whether taking low-dose doxycycline daily can help people with wet AMD who still have sub-retinal fluid despite regular anti-VEGF eye injections.
Related topics
Quick answers
How many Exudative Macular Degeneration clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.